CJC-1295 With DAC 10mg

Read the CJC-1295 with DAC Research Guide. Review the research context and evidence limitations.

Check the formulation before choosing: This listing is CJC-1295 with DAC. The CJC-1295 No DAC 10 mg vial and No DAC + Ipamorelin blend are separate products. They are not interchangeable simply because the listed milligram amounts may match.

CJC-1295 with DAC 10 mg: formulation matters

This listing is for the DAC-containing form of CJC-1295, with 10 mg total material per vial. DAC means Drug Affinity Complex. The modification supports albumin binding, a feature investigated in the original long-acting GHRH-analogue research.

With DAC versus No DAC

The DAC modification is part of the material’s identity. A No DAC listing should not be treated as the same compound simply because both names include CJC-1295. Studies of the albumin-binding analogue also should not automatically be applied to the No DAC product or to an Ipamorelin blend. Read the original albumin-binding CJC-1295 research.

Comparing laboratory materials

Use the formulation links above to compare the DAC, No DAC and combination listings. Check the compound identity and amount specified in your laboratory protocol, then consult the corresponding research guide for study details. The 10 mg label describes the total vial content; container capacity and solution concentration are separate measurements. Published research does not establish a clinical outcome for this SRP vial.

• Research material: CJC-1295 With DAC
• Listed strength and format: 10 mg Vial
• Research category: Growth Hormone Research

For laboratory research only. Not for human or animal use, consumption, administration, diagnosis, treatment, or therapeutic application.